SCHEMBL6440072

SCHEMBL6440072

Cc1ccc(Oc2ccc(C(C)(C)C)cc2)cc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
ALDH1A1 P00352 2/20 0.57
RAB9A P51151 2/20 0.57
NPC1 O15118 1/20 0.57
MAPK1 P28482 1/20 0.57
KMT2A Q03164 2/20 0.49
LMNA P02545 2/20 0.49
GFER P55789 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MEN1 O00255 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
TSHR P16473 1/20 0.43
BCHE P06276 4/20 0.43
ACHE P22303 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47863 0.88 KMT2A (0.49) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL10993100 0.85 KMT2A (0.60) MAPTHPGDALDH1A1NPC1KMT2A
SCHEMBL47864 0.85 KMT2A (0.60) MAPTHPGDALDH1A1NPC1KMT2A
SCHEMBL10819670 0.85 KMT2A (0.50) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL17147391 0.84 ALDH1A1 (0.57) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL24465444 0.84 KMT2A (0.53) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL12792078 0.83 KMT2A (0.45) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL12936587 0.83 RAB9A (0.52) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL22580675 0.83 KMT2A (0.45) MAPTHPGDALDH1A1RAB9ANPC1
SCHEMBL127279 0.82 RAB9A (0.77) MAPTHPGDALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170320867-A1 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2017-11-09 US disclosed
US-20160031872-A1 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2016-02-04 US disclosed
US-20140045813-A1 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-13 US disclosed
US-20050054882-A1 Diaryl ether condensation reactions NSF - DEITR 2005-03-10 US disclosed
US-6762329-B2 EFFECTS OF ACIDIC ACTIVATORS ON ULLMANN-TYPE COUPLINGS INVOLVING ELECTRON-POOR AND/OR RELATIVELY INSOLUBLE SUBSTRATES. MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-07-13 US disclosed
US-20030088128-A1 Diaryl ether condensation reactions NATIONAL SCIENCE FOUNDATION 2003-05-08 US disclosed
US-6395939-B1 CATALYTIC ETHERIFICATION AND CONDENSATION WITH COPPER CATALYSTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2002-05-28 US disclosed
WO-1999018057-A1 PREPARATION OF DIARYL ETHER BY CONDENSATION REACTIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1999-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045813-A1 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS BTK, SYK, LCK MAPT 4414/4885HPGD 2600/4885ALDH1A1 3329/4885
US-20050054882-A1 Diaryl ether condensation reactions NSFL1C, DERL1, UBE2M MAPT 1211/4885HPGD 2359/4885ALDH1A1 1863/4885
US-20030088128-A1 Diaryl ether condensation reactions NSFL1C, DERL1, UBE2M MAPT 1211/4885HPGD 2359/4885ALDH1A1 1863/4885
US-20170320867-A1 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS BTK, SYK, LCK MAPT 4414/4885HPGD 2600/4885ALDH1A1 3329/4885
US-20160031872-A1 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS BTK, SYK, LCK MAPT 4414/4885HPGD 2600/4885ALDH1A1 3329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.